Key points are not available for this paper at this time.
produced potent dose-independent reduction of serum glucose levels, compared to the potent hypoglycemic drug gliclazide.
Share your take
Add a clinician perspective alongside expert commentary.
Al-Wahaibi et al. (Sat,) studied this question.